![Young-Chul Sung](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Young-Chul Sung
Directeur/Membre du Conseil chez
PROGEN CO., LTD.
Fortune : 23 M $ au 31/05/2026
Profil
Young-Chul Sung was the founder of Genexine, Inc., founded in 1999, and served as Chief Executive Officer & Director from 2006 to 2014.
Dr. Sung is also the founder of SL Bigen Co. Ltd...
Current jobs include Director at the Korean Society For Molecular & Cellular Biology since 2003, Non-Executive Director at ProGen Co., Ltd. since 2024, Professor & Head-Biotechnology Center at Pohang University of Science & Technology since 2014, and Member of the Korean Society of Virology.
Former jobs include Director at Rezolute, Inc. from 2019 to 2020 and President of the Korean Association of Immunobiologists from 2005 to 2007.
Education includes doctorate degrees from Harvard University and the University of Minnesota, and an undergraduate degree from Yonsei University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PROGEN CO. LTD. 26,47% | 30/03/2026 | 6 494 629 ( 26,47% ) | 18 M $ | 31/05/2026 |
GENEXINE, INC. 4,47% | 20/01/2025 | 2 035 174 ( 4,47% ) | 5 M $ | 31/05/2026 |
Postes actifs de Young-Chul Sung
| Sociétés | Poste | Début |
|---|---|---|
| PROGEN CO., LTD. | Directeur/Membre du Conseil | 28/03/2024 |
Pohang University of Science & Technology
 Pohang University of Science & Technology Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 03/09/2010 |
Korean Society For Molecular & Cellular Biology | Directeur/Membre du Conseil | 01/01/2003 |
Korean Society of Virology | Corporate Officer/Principal | - |
Anciens postes connus de Young-Chul Sung
| Sociétés | Poste | Fin |
|---|---|---|
| REZOLUTE, INC. | Directeur/Membre du Conseil | 10/09/2020 |
Korean Association of Immunobiologists | President | 01/01/2007 |
SL Bigen Co. Ltd.
 SL Bigen Co. Ltd. BiotechnologyHealth Technology Provides research and development in bio genetic engineering | Fondateur | - |
| GENEXINE, INC. | Directeur Général | 28/08/2014 |
Formation de Young-Chul Sung
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
13
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pohang University of Science & Technology
Pohang University of Science & Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Minnesota
 University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yonsei University
 Yonsei University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Genexine, Inc.
 Genexine, Inc. BiotechnologyHealth Technology Engages in the research and development of bio-pharmaceuticals | Health Technology |
Korean Association of Immunobiologists | |
Rezolute, Inc.
 Rezolute, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative therapies for metabolic diseases related to chronic glucose imbalance | Health Technology |
SL Bigen Co. Ltd.
SL Bigen Co. Ltd. BiotechnologyHealth Technology Provides research and development in bio genetic engineering | Health Technology |
Progen Co., Ltd.
 Progen Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of medical sciences and pharmacy products | Commercial Services |
Korean Society For Molecular & Cellular Biology | |
Korean Society of Virology |
